| Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients (NCT02384967) | ANRS, Emerging Infectious Diseases | 2015-03-01 |
| IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence (NCT02140944) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2015-02-05 |
| A Safety and Immune Response Study of 2 Experimental HIV Vaccines (NCT02404311) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-02-02 |
| Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission (NCT02140255) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-01-23 |
| A Pilot Study of PrEP Acceptance Among Young Black MSM (NCT02671591) | Richard Crosby | 2015-01-05 |
| Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men (NCT02287961) | ANRS, Emerging Infectious Diseases | 2014-12-02 |
| Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure (NCT02263326) | Babafemi Taiwo | 2014-12-01 |
| Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment Regimens (NCT02411071) | University Hospital, Essen | 2014-12-01 |
| Glutathione and Function in HIV Patients (NCT02348775) | Baylor College of Medicine | 2014-11-01 |
| Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women (NCT02301507) | The University of Texas Health Science Center, Houston | 2014-11-01 |
| Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients (NCT02256579) | National Center for Global Health and Medicine, Japan | 2014-10-01 |
| A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients (NCT02291081) | University Hospital, Essen | 2014-10-01 |
| Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy (NCT02199613) | University of British Columbia | 2014-10-01 |
| A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination (NCT02362217) | University of Oxford | 2014-10-01 |
| Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions (NCT02135419) | AIDS Malignancy Consortium | 2014-09-24 |
| Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection (NCT02109224) | National Cancer Institute (NCI) | 2014-09-01 |
| Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500 (NCT02489487) | Viriom | 2014-09-01 |
| Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment (NCT02269605) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2014-09-01 |
| A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas (NCT02302950) | The University of Texas Health Science Center, Houston | 2014-09-01 |
| Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV (NCT01852942) | University of Minnesota | 2014-09-01 |
| Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir (NCT01902186) | Giovanni Di Perri | 2014-09-01 |
| Lactoferrin Treatment in HIV Patients (NCT01830595) | Jason Baker | 2014-09-01 |
| Dipyridamole for Immune Activation in HIV (NCT02121756) | Sharon Riddler | 2014-07-01 |
| Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe (NCT02216734) | Family AIDS Caring Trust | 2014-07-01 |
| Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection (NCT02134886) | National Cancer Institute (NCI) | 2014-07-01 |
| Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject (NCT02159599) | Fundacion SEIMC-GESIDA | 2014-07-01 |
| Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study (NCT02220868) | Saint Michael's Medical Center | 2014-07-01 |
| Immune Activation and Drug Absorption in HIV-Infected Patients (NCT01845298) | Drexel University | 2014-06-01 |
| The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia (NCT02012816) | University of North Carolina, Chapel Hill | 2014-06-01 |
| Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292) (NCT02131233) | Merck Sharp & Dohme LLC | 2014-05-23 |
| Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects (NCT02154360) | University of Pennsylvania | 2014-05-01 |
| Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients (NCT02093754) | ANRS, Emerging Infectious Diseases | 2014-05-01 |
| Dolutegravir + Rilpivirine Switch Study (DORISS) (NCT02069834) | Nantes University Hospital | 2014-05-01 |
| Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS (NCT02140775) | New York State Psychiatric Institute | 2014-04-01 |
| Fish Oil for HIV-Related Inflamm-aging and Immune Senescence (NCT02102724) | Rush University Medical Center | 2014-04-01 |
| Suicidality and Suicide Attempt Among HIV Patients on Efavirenz-containing Versus Efavirenz-free Antiretroviral Regimens (NCT02211807) | Bristol-Myers Squibb | 2014-04-01 |
| Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men (NCT02019771) | University of Nebraska | 2014-03-07 |
| Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers (NCT02038842) | ANRS, Emerging Infectious Diseases | 2014-03-01 |
| Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection (NCT01900015) | Juan Macías | 2014-02-03 |
| Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection (NCT01147107) | University of Hawaii | 2014-02-01 |
| Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa (NCT01905059) | ANRS, Emerging Infectious Diseases | 2014-02-01 |
| Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study (NCT02034838) | Ottawa Hospital Research Institute | 2014-01-01 |
| Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV (NCT01946139) | AIDS Malignancy Consortium | 2013-12-04 |
| EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients (NCT01886404) | University of Nebraska | 2013-12-01 |
| Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults (NCT01993706) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-19 |
| X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study (NCT01952587) | ANRS, Emerging Infectious Diseases | 2013-11-01 |
| Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection (NCT01249443) | AIDS Malignancy Consortium | 2013-11-01 |
| A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL) (NCT01900106) | University of Modena and Reggio Emilia | 2013-11-01 |
| Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort (NCT01934803) | Boston Medical Center | 2013-10-01 |
| Text Messaging to Improve HIV Testing Among Young Women in Kenya (NCT02527135) | University of Washington | 2013-09-01 |
| Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002 (NCT02118168) | Barbara Ensoli, MD, PhD | 2013-09-01 |
| Asha Improving Health and Nutrition of Indian Women With AIDS and Their Children (NCT02136082) | University of California, Los Angeles | 2013-08-01 |
| Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men (NCT02816879) | Jonsson Comprehensive Cancer Center | 2013-08-01 |
| Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients (NCT01899196) | ANRS, Emerging Infectious Diseases | 2013-07-01 |
| Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus (NCT01822522) | National Cancer Institute (NCI) | 2013-06-21 |
| Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults (NCT02109354) | HIV Vaccine Trials Network | 2013-06-18 |
| A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc (NCT01894776) | Ottawa Hospital Research Institute | 2013-06-01 |
| Factors Affecting PrEP Adherence (NCT02411630) | University of North Carolina, Chapel Hill | 2013-06-01 |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma (NCT01771107) | National Cancer Institute (NCI) | 2013-03-08 |
| Pilot Study of Diflunisal in HIV-infected Adults (NCT01676363) | University of British Columbia | 2013-03-01 |
| Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa (NCT02025868) | ANRS, Emerging Infectious Diseases | 2013-03-01 |
| Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection (NCT02485509) | Viriom | 2013-03-01 |
| An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) (NCT01769456) | University of North Carolina, Chapel Hill | 2013-03-01 |
| A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication (NCT01865786) | Gilead Sciences | 2013-01-01 |
| Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread? (NCT01895920) | ANRS, Emerging Infectious Diseases | 2013-01-01 |
| Use of Incentives to Retain Drug Users in HIV Therapy (NCT01488942) | University of British Columbia | 2012-12-01 |
| Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART). (NCT02054286) | Theravectys S.A. | 2012-12-01 |
| Clinical Trial to Reduce Drinking in Women With HIV (NCT01625091) | University of Florida | 2012-12-01 |
| Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir (NCT01818856) | Hospitales Universitarios Virgen del Rocío | 2012-12-01 |
| A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248) (NCT01717287) | Merck Sharp & Dohme LLC | 2012-11-16 |
| Partners Demonstration Project of PrEP and ART (NCT02775929) | University of Washington | 2012-11-01 |
| Alcohol's Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort (NCT01614626) | Boston Medical Center | 2012-11-01 |
| Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM). (NCT01769469) | University of North Carolina, Chapel Hill | 2012-11-01 |
| An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis (NCT01772823) | University of North Carolina, Chapel Hill | 2012-11-01 |
| Co-receptor Tropism Determination of HIV-1 Subtype A Spread in the Russian Federation Using V3-based Genotyping Tools (NCT01823614) | Dmitry Kireev | 2012-11-01 |
| Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort (NCT01740115) | Boston Medical Center | 2012-11-01 |
| Folinic Acid: Supplementation and Therapy (NCT02810275) | Hospital de Clinicas de Porto Alegre | 2012-10-01 |
| Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations (NCT01686750) | Johns Hopkins University | 2012-10-01 |
| The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling (NCT01843478) | Johns Hopkins University | 2012-10-01 |
| Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART (NCT01751646) | University of North Carolina, Chapel Hill | 2012-10-01 |
| Immune Reconstitution in HIV Disease (IREHIV) (NCT01702974) | Karolinska Institutet | 2012-09-01 |
| Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART (NCT01680094) | University of Aarhus | 2012-09-01 |
| Neural Correlates of Working Memory Training for HIV Patients (NCT02602418) | University of Hawaii | 2012-09-01 |
| Antiretroviral Therapy and Extreme Weight (NCT01805427) | Hopital Lariboisière | 2012-09-01 |
| Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP) (NCT01576731) | Hospital Clinic of Barcelona | 2012-07-01 |
| Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers (NCT02489435) | Viriom | 2012-07-01 |
| Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study (NCT01679964) | Lin, Hsi-Hsun, M.D. | 2012-07-01 |
| Linking Infectious and Narcology Care in Russia (NCT01612455) | Boston Medical Center | 2012-07-01 |
| Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients (NCT02934022) | Southern California Institute for Research and Education | 2012-06-01 |
| Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women (NCT01505114) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-06-01 |
| Testing and Linkage to Care for Injecting Drug Users in Kenya (NCT01557998) | Yale University | 2012-05-01 |
| HIV Disclosure and Medication Adherence, a Pilot Study (NCT01621412) | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | 2012-04-01 |
| Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence (NCT01509508) | ANRS, Emerging Infectious Diseases | 2012-03-01 |
| Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women (NCT01621347) | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | 2012-03-01 |
| Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX (NCT01629316) | University of North Carolina, Chapel Hill | 2012-03-01 |
| Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP) (NCT01533272) | Hospital Clinic of Barcelona | 2012-02-01 |
| Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection (NCT01529073) | Juan Macías | 2012-02-01 |
| the ANRS CO21 " Extreme " Cohort (CODEX) (NCT01520844) | ANRS, Emerging Infectious Diseases | 2012-02-01 |
| Use of Incentives to Engage Drug Users in HIV Therapy (NCT01526421) | University of British Columbia | 2012-02-01 |
| Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy (NCT01728961) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2012-02-01 |